These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3115394)

  • 1. Comparison of antiemetic efficacy of domperidone, metoclopramide, and dexamethasone in patients receiving outpatient chemotherapy regimens.
    Cunningham D; Evans C; Gazet JC; Ford H; Pople A; Dearling J; Chappell D; Coombes C
    Br Med J (Clin Res Ed); 1987 Jul; 295(6592):250. PubMed ID: 3115394
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiemetic efficacy of high-dose dexamethasone: randomized, double-blind, crossover study with high-dose metoclopramide in patients receiving cancer chemotherapy.
    Ibrahim EM; Al-Idrissi HY; Ibrahim A; Absood G; Al-Dossary E; Al-Jammaa A; Al-Ethan S; Eliopoulos A
    Eur J Cancer Clin Oncol; 1986 Mar; 22(3):283-8. PubMed ID: 3519233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiemetic efficacy of dexamethasone. Randomized, double-blind, crossover study with prochlorperazine in patients receiving cancer chemotherapy.
    Markman M; Sheidler V; Ettinger DS; Quaskey SA; Mellits ED
    N Engl J Med; 1984 Aug; 311(9):549-52. PubMed ID: 6379459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind trial comparing antiemetic efficacy and toxicity of metoclopramide versus methylprednisolone versus domperidone in patients receiving doxorubicin chemotherapy alone or in combination with other antiblastic agents.
    Basurto C; Roila F; Bracarda S; Tonato M; Ballatori E; Del Favero A
    Am J Clin Oncol; 1988 Oct; 11(5):594-6. PubMed ID: 3177262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The control of chemotherapy-induced nausea and vomiting].
    Shinkai T; Saijo N; Sawamura N; Funaki U; Takahashi S; Yokoyama S; Fujita J; Futami H; Sasaki Y; Shimizu E
    Gan No Rinsho; 1985 Jun; 31(7):779-91. PubMed ID: 3897622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of starting antiemetic treatment 24 hours before or concurrently with cytotoxic chemotherapy.
    Williams CJ; Davies C; Raval M; Middleton J; Luken J; Stone B
    BMJ; 1989 Feb; 298(6671):430-1. PubMed ID: 2495050
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
    Bruntsch U; Drechsler S; Eggert J; Gosse H; Ukena D; Imhoff W; Faerber L
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of antiemetics for vomiting due to cancer chemotherapy in children].
    Ise T; Ohira M; Omiya A; Hirose M; Shibata T
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1108-18. PubMed ID: 6764113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of two outpatient antiemetic regimens for cancer chemotherapy.
    Pruitt BT; Justice RL; Periman P
    Tex Med; 1985 Jul; 81(7):44-5. PubMed ID: 3898458
    [No Abstract]   [Full Text] [Related]  

  • 11. Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin.
    Kris MG; Gralla RJ; Tyson LB; Clark RA; Cirrincione C; Groshen S
    J Clin Oncol; 1989 Jan; 7(1):108-14. PubMed ID: 2642536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.
    Madej G; Krzakowski M; Pawinski A; Lasota W; Rogowski W; Skoneczna I
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):3-6. PubMed ID: 9113119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy.
    Bhatia A; Tripathi KD; Sharma M
    Indian J Med Res; 2003 Jul; 118():33-41. PubMed ID: 14748464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of nausea and emesis during cytostatic therapy. Antiemetic efficacy of high-dosage oral metoclopramide without and with prednisone].
    Senn HJ; Köhler M; Glaus A; Bachmann-Mettler I; Weigand W
    Dtsch Med Wochenschr; 1986 Jan; 111(4):129-35. PubMed ID: 3510848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ondansetron versus metoclopramide, both combined with dexamethasone, in the prevention of cisplatin-induced delayed emesis. The Italian Group for Antiemetic Research.
    J Clin Oncol; 1997 Jan; 15(1):124-30. PubMed ID: 8996133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buprenorphine versus domperidone in chemotherapy-induced emesis: a pilot study.
    Dullemond-Westland AC; Neijt JP; Nortier JW; Sitsen JM
    Radiother Oncol; 1986 Jun; 6(2):127-33. PubMed ID: 3526421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative trial between two drugs in the treatment of vomiting induced by anti-cancer chemotherapy (author's transl)].
    Zylberait D; Krulik M; Audebert AA; Debray J
    Sem Hop; 1981 Jan 8-15; 57(1-2):47-9. PubMed ID: 6258237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nabilone: an alternative antiemetic for cancer chemotherapy.
    Dalzell AM; Bartlett H; Lilleyman JS
    Arch Dis Child; 1986 May; 61(5):502-5. PubMed ID: 3013104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antiemetic activity of tetrahydrocannabinol versus metoclopramide and thiethylperazine in patients undergoing cancer chemotherapy.
    Colls BM; Ferry DG; Gray AJ; Harvey VJ; McQueen EG
    N Z Med J; 1980 Jun; 91(662):449-51. PubMed ID: 6250106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis. Italian Group For Antiemetic Research.
    Lancet; 1992 Jul; 340(8811):96-9. PubMed ID: 1352024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.